Not known Factual Statements About Ivosidenib
Results of the next comparative review have been documented by Flinn et al. This is a section III randomized Intergroup trial evaluating FC regimen vs . FAMP on your own in 278 sufferers receiving their first chemotherapy program for B-CLL. Dosages of FC timetable were similar to the primary study.101–104 The target of acquiring donor engraftment